Inventor · disambiguated record
Ignace Lasters
Also filed as: LASTERS IGNACE · LASTERS IGNACE JOSEPH ISABELLA
16 granted patents·23 pending applications·166 citations·filing 1989–2022
92Inventor score
Top patents by PatentIndex Score
39 records- 0184US5747449ABovine pancreatic trypsin inhibitor derived inhibitors of factor XACORVAS INT INC·Filed 1993·Granted May 5, 1998·70 cites·3 claims
- 0282US7702465B2Method, computing routine, device for predicting properties of MHC/peptide complexes, and data and peptides produced therefromALGONOMICS N V·Filed 2003·Granted Apr 20, 2010·13 cites·17 claims
- 0379US8571806B2Method for generating information related to the molecular structure of a biomoleculeDESMET JOHAN·Filed 2010·Granted Oct 29, 2013·3 cites·42 claims
- 0472US10000570B2Antibody variants having modifications in the constant regionGENMAB AS·Filed 2015·Granted Jun 19, 2018·1 cites·17 claims
- 0572US8229721B1Apparatus and method for structure-based prediction of amino acid sequencesDESMET JOHAN·Filed 2000·Granted Jul 24, 2012·2 cites·13 claims
- 0671US2021155699A1Antibody variants having modifications in the constant regionGENMAB AS·Filed 2020·Application pending·0 cites
- 0767US5807980ABovine pancreatic trypsin inhibitor derived inhibitors of factor VIIa-tissue factor complexCORVAS INT INC·Filed 1993·Granted Sep 15, 1998·37 cites·4 claims
- 0865US2012202247A1Method, computing routine, device for predicting properties of mhc/peptide complexes, and data and peptides produced therefromLASTERS IGNACE·Filed 2012·Application pending·0 cites
- 0962US2013211808A2Apparatus and method for structure-based prediction of amino acid sequencesDESMET JOHAN·Filed 2012·Application pending·0 cites
- 1061US2010099613A1Peptides for inducing a ctl and/or htl response to hepatitis c virusGENIMMUNE·Filed 2009·Application pending·0 cites
- 1160US2018319888A1Antibody variants having modifications in the constant regionGENMAB AS·Filed 2018·Application pending·0 cites
- 1259US2011294983A1Single-chain antiparallel coiled coil proteinsDESMET JOHAN·Filed 2009·Application pending·0 cites
- 1358US2006093617A1Peptides for inducing a CTL and/or HTL response to hepatitis C virusEPIMMUNE INC·Filed 2005·Application pending·0 cites
- 1458US2010168398A1Method, computing routine, device for predicting properties of MHC/peptide complexes, and data and peptides produced therefrom.LASTERS IGNACE·Filed 2010·Application pending·0 cites
- 1556US2010216187A1Amino acid sequences that bind to a desired molecule in a conditional mannerABLYNX NV·Filed 2007·Application pending·0 cites
- 1655US2011245463A1Apparatus and method for structure-based prediction of amino acid sequencesALGONOMICS N V·Filed 2011·Application pending·0 cites
- 1751US2012148571A1Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereofLASTERS IGNACE JOSEPH ISABELLA·Filed 2011·Application pending·0 cites
- 1850US5310665AGlucose isomerases having altered substrate specificityPLANT GENETIC SYSTEMS NV·Filed 1991·Granted May 10, 1994·12 cites·16 claims
- 1950US5290690AMethods and means for controlling the stability of proteinsPLANT GENETIC SYSTEMS NV·Filed 1989·Granted Mar 1, 1994·12 cites·12 claims
- 2049US9217011B2Non-natural proteinaceous scaffold made of three non-covalently associated peptidesDESMET JOHAN·Filed 2008·Granted Dec 22, 2015·0 cites·14 claims
- 2149US8538706B2Method for affinity scoring of peptide/protein complexesDESMET JOHAN·Filed 2011·Granted Sep 17, 2013·0 cites·20 claims
- 2249US5384257AGlucose isomerases with an altered pH optimumGIST BROCADES NV·Filed 1993·Granted Jan 24, 1995·9 cites·15 claims
- 2349US2010129368A9Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereofABLYNX NV·Filed 2007·Application pending·0 cites
- 2449US2004009507A1Concatenated nucleic acid sequenceDOMANTIS LTD·Filed 2003·Application pending·0 cites
- 2547US10087249B2Alphabody libraries and methods for producing the sameCOMPLIX SA·Filed 2016·Granted Oct 2, 2018·0 cites·9 claims
- 2647US2024317807A1Mcl-1 binding alphabodies and uses thereofCOMPLIX NV·Filed 2022·Application pending·0 cites
- 2745US5340738AModified prokaryotic glucose isomerase enzymes with altered pH activity profilesGIST BROCADES NV·Filed 1991·Granted Aug 23, 1994·7 cites·13 claims
- 2845US2008312840A1Method for Affinity Scoring of Peptide/Protein ComplexesALGONONMICS N V·Filed 2006·Application pending·0 cites
- 2944US9315805B2Alphabody libraries and methods for producing the sameDESMET JOHAN·Filed 2011·Granted Apr 19, 2016·0 cites·5 claims
- 3041US2005214857A1Method for displaying loops from immunoglobulin domains in different contextsABLYNX NV·Filed 2002·Application pending·0 cites
- 3140US2016039867A1Single-chain antiparallel coiled coil proteinsCOMPLIX NV·Filed 2015·Application pending·0 cites
- 3237US2012177676A1Alphabodies for hiv entry inhibitionDESMET JOHAN·Filed 2010·Application pending·0 cites
- 3336US9701717B2Polypeptides specifically binding to IL-23COMPLIX NV·Filed 2013·Granted Jul 11, 2017·0 cites·13 claims
- 3434US2012020952A1Methods for producing mixtures of antibodiesPARREN PAUL·Filed 2010·Application pending·0 cites
- 3532US10023647B2Polypeptides capable of cellular internalizationCOMPLIX NV·Filed 2013·Granted Jul 17, 2018·0 cites·11 claims
- 3632US2013261049A1Alphabodies specifically binding to class-i viral fusion proteins and methods for producing the sameDESMET JOHAN·Filed 2011·Application pending·0 cites
- 3731US2014057830A1Alphabodies specifically binding to cytokines or growth factors and/or cytokine or growth factor receptorsLASTERS IGNACE·Filed 2012·Application pending·0 cites
- 3831US2014363434A1Binding agents to intracellular target moleculesCOMPLIX NV·Filed 2013·Application pending·0 cites
- 3930US2014294828A1Alphabodies specifically binding to viral proteins and methods for producing the sameDESMET JOHAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ignace Lasters files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →